MedPath

Effectiveness and safety of Formulation HB01 for instant relief from heartburn.

Phase 4
Conditions
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Registration Number
CTRI/2023/10/058553
Lead Sponsor
utrin GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Gender: Non-pregnant, non-lactating female aged between 18 to 65.

2.Subject willing to give written informed consent

3.Women of child bearing potential must have a negative urine pregnancy test.

4.Free of any Kidney and Heart disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE.

Exclusion Criteria

1.Subjects who are pregnant, breast feeding, or planning to become pregnant during the study.

2.Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product.

3.Have participated in any interventional clinical trial in the previous 30 days.

4.Have a known sensitivity to sorbitol and any of the constituents of the test product.

5.Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years.

6.Patients with Cholecystectomy.

7.Subject with an elevated level of calcium.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath